β-Carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells

Integrative Cancer Therapies

Volumn 6, Issue 3, 2007, Pages 258-270

  Guruvayoorappan, C ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

carotene; Activated transcription factor; Angiogenesis; Cytokine profile; HUVEC; Nuclear factor B

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; BETA CAROTENE; BINDING PROTEIN; CYCLIC AMP; CYTOKINE; ELEMENT; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN C FOS; PROTEIN LYSINE 6 OXIDASE; PROTEIN P50; SYNAPTOTAGMIN I; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; C57BL 6 MOUSE; CAPILLARY; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME RELEASE; EXPERIMENTAL STUDY; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR RING;

ACTIVE TRANSPORT, CELL NUCLEUS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; BETA CAROTENE; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYTOKINES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NF-KAPPA B; RATS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSCRIPTION FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548142633     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735407305978     Document Type: Article

References (70)

1. Carmeliet P., Jain RK Angiogenesis in cancer and other diseases. Nature (Lond). 2000 ; 407: 249-257.
2. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002 ; 6 (suppl 16). 15-18.
3. Kisley LR, Barrett BS, Bauer AK, et al. Genetic abalation of inducible nitric oxide synthase decrease mouse lung tumorigenesis. Cancer Res. 2002 ; 62: 6850-6856.
4. Dicker AP, Williams TL, Grant DS Targeting angiogenic process by combination rofecoxib and ionizing radiation. Am J Clin Oncol. 2001 ; 24: 438-442.
5. Clinton SK Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev. 1998 ; 56: 35-51.
6. Paollini M., Abdel-Rahman SZ, Sapone A., et al. Beta-carotene: a cancer chemopreventive agent or co-carcinogen? Mutat Res. 2003 ; 543: 195-200.
7. Burton GW, Ingold KU β-carotene: an unusual type of lipid antioxidant. Science. 1984 ; 224: 569-573.
8. Halliwell B., Gutteridge Jmc. Free Radicals in Biology and Medicine. 3 rd ed. New York, NY: Oxford University Press ; 1999: 223-225.
9. Pradeep CR, Kuttan G. Effect of beta-carotene on the inhibition of lung metastasis in mice. Phytomedicine. 2003 ; 10: 159-164.
10. Guruvayoorappan. C., Kuttan G. β-Carotene down regulates iNOS gene expression and induces apoptosis by suppressing bcl-2 expression and activating caspase-3 and p53 genes in B16F-10 melanoma cells. Nutr Res. 2007 ; 27: 336-342..
11. Jaffe EA, Nachman RL, Becker CG, Minick CR Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973 ; 52: 2745-2756.
12. Leyon PV, Kuttan G. Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumor specific angiogenesis. J Exp Clin Cancer Res. 2003 ; 22: 77-83.
13. Kishi K., Petersen S., Petersen C., et al. Preferential enhancement of tumor radio response by COX-2 inhibition. Cancer Res. 2000 ; 60: 1326-1331.
14. Pan Q., Kleer CG, van Golen KL, et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002 ; 62: 4854-4859.
15. Cole SP Rapid chemosensitivity testing of human lung tumor cells using MTT assay. Cancer Chemother Pharmacol. 1986 ; 17: 259-263.
16. Campling BG, Pym J., Baker HM, Cole SP, Lam YM Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer. 1991 ; 63: 75-83.
17. Gupta K., Kshirsagar S., Chang L., et al. Morphine stimulates angiogenesis by activating proangiogenic and survival promoting signaling and promotes breast tumor growth. Cancer Res. 2002 ; 62: 4491-4498.
18. Dignam JD, Lebovitz RM, Roeder RG Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res. 1983 ; 11: 1475-1489.
19. Shen Z., Peedikayil J., Olson GK, Siebert PD, Fang Y. Multiple transcription factor profiling by enzyme-linked immunoassay. Biotechniques. 2002 ; 32: 1168-1177.
20. Mayne ST β-Carotene, carotenoids and disease prevention in humans. FASEB J. 1996 ; 10: 690-701.
21. Paollini M., Abdel-Rahman SZ, Sapone A., et al. Beta-carotene: a cancer chemopreventive agent or co-carcinogen? Mutat Res. 2003 ; 543: 195-200.
22. Epstein KR The role of carotenoids in the risk of lung cancer. Semin Oncol. 2003 ; 30: 86-93.
23. Caraballoso M., Sacristan M., Serra C., Bonfill M. Drugs for preventing lung cancer in healthy people. Cochrane Database Syst Rev. 2002: CD002141.
24. Ponce ML, Nomizu M., Kleinman HK An angiogenic laminin site and its antagonist bind through the alpha (v) beta 3 and alpha 5 beta 1 integrins. FASEB J. 2001 ; 15: 1389-1397.
25. Dembinska KA, Polus A., Kiec WB, et al. Proangiogenic activity of beta-carotene is coupled with the activation of endothelial cell chemotaxis. 2005 ;1740: 222-239.
26. Rofstad EK, Halsor EF Vascular endothelial growth factor, interleukin-8, platelet derived endothelial cell growth factor and fibroblast growth factor promotes angiogenesis and metastasis in human melanoma xenografts. Cancer Res. 2000 ; 60: 4932-4938.
27. Taloor D., Sing AK, Sindhu GS, Pradad PV, Kleinman HK, Maheshwari RK Inhibition of angiogenic differentiation of human umbilical vein endothelial cell by curcumin. Cell Growth Diff. 1998 ; 9: 305-312.
28. Schwarz M., Murphy PM Kaposi sarcoma associated herpes virus G protein-coupled receptor constitutively activates NFκB and induces proinflammatory cytokine and cytokine pro duction via a C-terminal signaling determinant. J Immunol. 2001 ; 167: 505-513.
29. Huang S., De Guzman A., Buckano CD, Fidler IJ Level of interleukin-8 expression by metastatic human melanoma cells directly correlates constitutive NF-κB activity. Cell Mol Ther. 2000 ; 6: 9-17.
30. Yoneda J., Kumyasu H., Crupsem MA Expression of angiogenesis related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst. 1998 ; 90: 447-454.
31. Distler Jhw, Hirth A., Kurowska-Stolarska M., Gay RE, Gay S., Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med. 2003 ; 9: 677-684.
32. Cerami A. Inflammatory cytokines. Clin Immunol Immunopathol. 1992 ; 62: S3 - S10.
33. Walsh DA, Pearson CI Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res. 2001 ; 31: 147-153.
34. Chen Z., Malhotra PS, Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res. 1999 ; 5: 1369-1379.
35. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow ? Lancet. 2001 ; 357: 539-545.
36. Dinarello CA Biologic basis for interleukin-1 in disease. Blood. 1996 ; 87: 2095-2147.
37. Voronov E., Shouval DS, Krelin Y., et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A. 2003 ; 100: 2645-2650.
38. Waterston A., Bower M. TNF and cancer: back to Virchow ? Lancet. 2004 ; 357: 539-545.
39. Josko J., Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit. 2004 ; 10: 89-98.
40. Shin KY, Moon HS, Park HY, et al. Effects of tumor necrosis factor-alpha and interferon gamma on expression of matrix metalloproteinase-2 and -9, in human bladder cancer cells. Cancer Lett. 2000 ; 159: 127-134.
41. Pradeep CR, Kuttan G. Piperine is a potent inhibitor of nuclear factor kappa B (NF-κB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int Immunopharmacol. 2004 ; 4: 1795-1803.
42. Bussolino F., Ziche M., Wang JM, et al. In vitro and in vivo activation of endothelial cells by colony stimulating factors. J Clin Invest. 1991 ; 87: 986-995.
43. Hoeben A., Landuyt B., Highley MS, Wildiers H., Van Oosterom AT, De Bruijn EA Vascular endothelial growth factors and angiogenesis. Pharmacol Rev. 2004 ; 56: 549-580.
44. Bloomston A., Shafi A., Zervos EE, Rosemurgy AS TIMP-1 over-expression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. J Surg Res. 2002 ; 102: 39-44.
45. Gomez DE, Alonso DF, Yoshiji H., Thorgeirsson UP Tissue inhibitors of metalloproteinases: structure, regulation, and biological functions. Eur J Cell Biol. 1997 ; 74: 111-122.
46. Jiang Y., Goldberg ID, Shi YE Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 2002 ; 21: 2245-2252.
47. Bonanno E., Lurlaro M., Madri JA, Nicosia RF Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model. In Vitro Cell Dev Biol Anim. 2000 ; 36: 336-340.
48. Myllyla R., Kuutti-Savolainen ER, Kivirikko KI The role of ascorbate in the prolyl hydroxylase reaction. Biochem Biophys Res Commun. 1978 ; 83: 441-448.
49. Kagan HM, Trackman PC Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol. 1991 ; 5: 206-210.
50. Krebs CJ, Krawetz SA Lysyl oxidase copper-talon complex: a model. Biochem Biophys Acta. 1993 ; 1202: 7-12.
51. Palamakumbura AH, Sommer P., Trackman PC Autocrine growth factor regulation by lysyl oxidase expression in transformed fibroblasts. J Biol Chem. 2003 ; 278: 30781-30787.
52. Trivedy C., Warnakulasuriya KA, Hazarey VK, et al. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med. 1999 ; 28: 246-251.
53. Siebenlist U., Franzono G., Brown K. Structure regulation and function of NF-κB. Annu Rev Cell Biol. 1994 ; 10: 405-455.
54. Liud DS, Hochwald SN, Malaty J., et al. Nuclear factor-κ B is upregulated in coleorectal cancer. Surgery. 2001 ; 130: 363-369.
55. Nakshatri H., Bhat-Nakshatri P., Martin DA, Goulet RJ, Sledge GW Constitutive activation of NF-κB during progression of breast cancer to hormone independent growth. Mol Cell Biol. 1997 ; 17: 3629-3639.
56. Mori N., Fujii M., Ikada S., et al. Constitutive activation of NF-κB on primary adult T-cell leukemia cells. Blood. 1999 ; 93: 2360-2368.
57. Neurath MF, Becker C., Barbulescu K. Role of NF-κB in immune and inflammatory response in the gut. Gut. 1998 ; 439: 856-860.
58. Sun SC, Xiao G. Degrgulation of NF-κB and its upstream kinases in cancer. Cancer Metastasis Rev. 2003 ; 22: 405-422.
59. Karin M., Delhase M. The I kappa B kinase (IKK) and NF-κB: key elements of proinflammatory signaling. Semin Immunol. 2000 ; 12: 85-98.
60. Silverman N., Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001 ; 15: 2321-2342.
61. Karin M., Liu Z., Zandi E. Ap-1 function and regulation. Curr Opin Cell Biol. 1997 ; 9: 240-246.
62. Angel P., Szabowski A., Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene. 2001 ; 20: 2413-2423.
63. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002 ; 4: E131 - E136.
64. Vincenti MP, White LA, Schroen DJ, Benbow U., Brinckerhoff CE Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr. 1996 ; 6: 391-411.
65. Wastermarck J., Kahari VM Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999 ; 13: 781-792.
66. Zerbini LF, Wang Y., Cho JY, Libermann TA Constitutive activation of nuclear factor-κB p50/p65 and Fra-1 and Jun-D essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res. 2003 ; 63: 2206-2215.
67. Huang C., Huang Y., Lee J., et al. Inhibition of benzopyrene diol epoxide-induced transactivation of activated protein-1 and nuclear factor-κB by black raspberry extracts. Cancer Res. 2003 ; 63: 2206-2215.
68. Huang C., Chen N., Ma WY, Dong Z. Vanadium induce AP-1 and NF-κB dependent transcription activity. Int J Oncol. 1998 ; 13: 711-715.
69. Angel P., Karin M. The role of Jun, Fos and the AP-complex in cell proliferation and transformation. Biochim Biophys Acta. 1991 ; 1072: 129-157.
70. Zhong H., Voll R., Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell. 1999 ; 1: 29411-29416.